PTC Inc. (PTC)

PTC Therapeutics is poised for a potential turnaround with key FDA reviews in 2025 for vatiquinone and sepiapterin, despite past revenue declines. The company maintains a strong cash position of over ...

PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock?

Sometimes, the headline numbers don't tell the whole story. That's definitely the case with industrial software company PTC (PTC 0.05%) and workflow technology company Trimble (TRMB 1.11%).

The prospect of several more weeks of winter after Punxsutawney Phil saw his shadow may have your mind fretful about more frosty weather, but that shouldn't distract you from the S&P 500's red-hot per...

None of these three stocks are conventionally cheap, but they all have huge growth potential from megatrends already in place, making them attractive stocks for investors to buy for the long term. Her...

Shares in industrial software company PTC (PTC -9.84%) were lower by 8.8% in the week to Thursday afternoon. The move comes after a poorly received first-quarter 2025 earnings released on Wednesday.

PTC's Q1 performance is driven by strength in its subscription-based business model and innovative product portfolio against a volatile sales backdrop.

PTC Inc. (NASDAQ:PTC ) Q1 2025 Earnings Conference Call February 5, 2025 5:00 PM ET Company Participants Matt Shimao - Head of Investor Relations Neil Barua - President and Chief Executive Officer Kri...

The headline numbers for PTC Inc. (PTC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim...

PTC Inc. (PTC) came out with quarterly earnings of $1.10 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1.11 per share a year ago.